| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.8 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |